Pharmaceuticals

Global Nicotinamide Adenine Dinucleotide Market Forecast to Reach $11.64 Billion by 2030 at 15.8% CAGR

April 9, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Nicotinamide Adenine Dinucleotide Market By The End Of 2030?

The nicotinamide adenine dinucleotide market has shown substantial growth in recent times. It is anticipated to expand from $5.59 billion in 2025 to $6.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.1%. This past growth is largely attributable to factors such as the escalating demand for anti-aging supplements, increased research concerning cellular metabolism, a heightened focus on preventive healthcare, the broadening of nutraceutical distribution channels, and the greater adoption of wellness and biohacking products.

The market for nicotinamide adenine dinucleotide is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $11.65 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 15.8%. This projected growth can be attributed to several factors, including heightened consumer expenditure on products promoting longevity and vitality, the increasing integration of NAD precursors into common supplements, the broadening reach of IV therapy and regenerative clinics, a growing focus from the pharmaceutical sector on NAD for managing chronic diseases, and the expanding presence of online personalized supplement programs. Key trends expected during this period involve technological progress in sustained-release and liposomal delivery methods, breakthroughs in multi-ingredient formulations aimed at longevity, the evolution of NAD-based active ingredients for dermatology and skincare, ongoing research and development into therapeutic-grade NAD for neurological and metabolic conditions, and improvements in biomarker-driven personalized supplementation platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30680&type=smp

What Primary Drivers Are Shaping The Development Of The Nicotinamide Adenine Dinucleotide Market?

The growing occurrence of age-related and metabolic conditions is anticipated to drive the expansion of the nicotinamide adenine dinucleotide market in the future. These disorders encompass health issues like diabetes, obesity, cardiovascular ailments, and neurodegenerative conditions, all linked to aging, metabolic impairment, and cellular dysfunction. Their prevalence is increasing due to aging populations and the widespread adoption of unhealthy lifestyles, including sedentary habits, excessive caloric consumption, and escalating obesity rates. Nicotinamide adenine dinucleotide aids in managing these conditions by its vital involvement in cellular energy metabolism, mitochondrial function, and DNA repair, all crucial for upholding metabolic well-being and mitigating age-related cellular deterioration. For example, the International Diabetes Federation, a Belgium-based non-profit organization, forecast in February 2025 that the global population aged over 65 with diabetes will climb to 195.2 million, representing 19.6%, by 2030, and further to 276.2 million by 2045. This underscores a substantial increase in the diabetes burden within aging societies over the next 25 years, carrying significant public health and economic consequences. Consequently, the increasing prevalence of age-related and metabolic disorders is fueling the expansion of the nicotinamide adenine dinucleotide market.

Which Segment Classifications Shape The Nicotinamide Adenine Dinucleotide Market?

The nicotinamide adenine dinucleotide market covered in this report is segmented –

1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations

2) By Grade: Food Grade, Pharmaceutical Grade, Other Grades

3) By Distribution Channel: Online and E-commerce, Offline Channels

4) By Application: Dietary Supplements and Wellness, Pharmaceuticals and Therapeutics, Cosmetics and Dermatology, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology

5) By End User: Individual Consumers, Healthcare Providers, Pharmaceutical Companies

Subsegments:

1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules

2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules

3) By Nicotinamide Adenine Dinucleotide Injection and Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends

4) By Specialized Anti-Aging and Metabolic Formulations: Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas

5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends

5) By Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation Gels

How Are Trends Impacting The Nicotinamide Adenine Dinucleotide Market?

Leading companies within the nicotinamide adenine dinucleotide market are concentrating on developing advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to aid in anti-aging and enhance skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements are defined as dietary or topical products engineered to elevate nicotinamide adenine dinucleotide (NAD+) levels in skin cells, thereby supporting cellular energy, repair, and anti-aging processes to improve skin health and appearance. For example, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience company, unveiled Tru Niagen Beauty, the first NAD+ skincare supplement made available in the United States, incorporating a precise combination of clinically investigated ingredients, including its patented nicotinamide riboside (Niagen). This specific formulation is crafted to bolster cellular energy production, skin vitality, and overall wellness by boosting NAD+ availability, which naturally diminishes with advancing age.

Who Are The Top Market Participants Influencing The Nicotinamide Adenine Dinucleotide Market?

Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.

Read the full nicotinamide adenine dinucleotide market report here:

https://www.thebusinessresearchcompany.com/report/nicotinamide-adenine-dinucleotide-market-report

Which Region Is Anticipated To See The Fastest Growth In The Nicotinamide Adenine Dinucleotide Market?

North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide adenine dinucleotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nicotinamide Adenine Dinucleotide Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30680&type=smp

Browse Through More Reports Similar to the Global Nicotinamide Adenine Dinucleotide Market 2026, By The Business Research Company

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Peptide And Oligonucleotide Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-and-oligonucleotide-cdmo-global-market-report

n methyl 2 pyrrolidone nmp market

https://www.thebusinessresearchcompany.com/report/n-methyl-2-pyrrolidone-nmp-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795